UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039032
Receipt number R000044508
Scientific Title Is an operation device with a center of gravity measurement function (locobot) effective for improving motor function? -Focus on motor function after total hip arthroplasty and total knee arthroplasty-
Date of disclosure of the study information 2019/12/30
Last modified on 2023/11/11 15:53:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Is an operation device with a center of gravity measurement function (locobot) effective for improving motor function?

Acronym

Is an operation device with a center of gravity measurement function (locobot) effective for improving motor function?

Scientific Title

Is an operation device with a center of gravity measurement function (locobot) effective for improving motor function?
-Focus on motor function after total hip arthroplasty and total knee arthroplasty-

Scientific Title:Acronym

Is an operation device with a center of gravity measurement function (locobot) effective for improving motor function?

Region

Japan


Condition

Condition

Hip osteoarthritis
Knee osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to verify whether exercise using an operating device with a center of gravity measurement function (locobot) is effective for improving motor function.
The subjects are patients after total hip arthroplasty (THA) and total knee arthroplasty (TKA).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Before surgery, 14days after surgery, 6 weeks after surgery, 3 months after surgery, 6 months after surgery , 12 months after surgery
1. Temporal and spatial factors in gait:
walking rate (cadence), stride time, step time, one-leg support time, two-legged support time, stride length, step length, and walking speed.

Key secondary outcomes

Before surgery, 14days after surgery, 6 weeks after surgery, 3 months after surgery, , 6 months after surgery , 12 months after surgery
2. Body center-of-gravity motion in gait: Vertical, lateral, and horizontal width
3. Lower limb loading rate in static standing posture
Average load, average load percentage, average load change
Maximum load, maximum load ratio, maximum load change
4. Body center of gravity sway in static upright posture:
Total trajectory length, rectangular area, external area, mean center of sway displacement
5. Time Up & Go test
6. Functional Reach test
7. Berg Balance Scale
8. One leg stand test
9. Rise test in mobility, 2-step test, Locomo 25


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Intervention period: 2 days after surgery to 12 months after surgery

Interventions/Control_2

Intervention frequency: once a day

Interventions/Control_3

Intervention time: 10 minutes

Interventions/Control_4

Intervention 1: THA, locobot/control
Intervention 2: THA, locobot/control

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Those who are over 40 years old.
Those who have undergone THA or TKA.
Those who are deemed appropriate for this study.

Key exclusion criteria

Patients who have been instructed by the attending physician to limit lower limb loads after surgery.
Those who have higher brain dysfunction or cognitive decline.
Other subjects that the person in charge of implementation judged to be inappropriate as a research subject.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Etsuo
Middle name
Last name Chosa

Organization

University of Miyazaki, Miyazaki, Miyazaki, Japan

Division name

Faculty of Medicine, Department of Orthopaedic Surgery

Zip code

889-1692

Address

5200 Kihara Kiyotake Miyazaki, Miyazaki, Japan

TEL

0985-85-0986

Email

chosa@med.miyazaki-u.ac.jp


Public contact

Name of contact person

1st name Shigeaki
Middle name
Last name Miyazaki

Organization

University of Miyazaki Hospital, Miyazaki, Miyazaki, Japan

Division name

Rehabilitation Unit

Zip code

889-1692

Address

5200 Kihara Kiyotake Miyazaki, Miyazaki, Japan

TEL

0985-85-9849

Homepage URL


Email

03-5-23@med.miyazaki-u.ac.jp


Sponsor or person

Institute

University of Miyazaki Hospital, Miyazaki, Miyazaki, Japan

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Support Center, University of Miyazaki Hospital, Miyazaki, Miyazaki, Japan

Address

5200 Kihara Kiyotake Miyazaki, Miyazaki, Japan

Tel

0985-85-9403

Email

igakubu_kenkyu@med.miyazaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

宮崎大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 30 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 12 Month 30 Day

Date of IRB

2020 Year 07 Month 15 Day

Anticipated trial start date

2020 Year 04 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 12 Month 30 Day

Last modified on

2023 Year 11 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044508


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name